Abstract:Abstract Esophageal cancer (EC) is a leading cause of cancer-related death in the west 1 . Esophageal squamous cell carcinoma (SCC) is the most common type of EC worldwide. However, in Western countries, including the United States, esophageal adenocarcinoma (EAC) is the most common 2 . EAC is most common in the lower esophagus whereas SCC is most common in the middle and upper esophagus 3 . The incidence of EAC has increased dramatically in western countries over the past few decades. 2 3 The exact reason for this rise in EAC has not been clearly understood. However, an increase in the prevalence of EAC risk factors is postulated as a potential explanation 4 . Although there are many identifiable EAC risk factors, including gastroesophageal reflux disease (GERD), obesity, male sex, White race, and smoking 5 6 7 , Barrett’s esophagus (BE) remains the major precursor lesion of esophageal adenocarcinoma. BE develops when there is a change in the normal squamous lining of the esophageal mucosa into intestinal metaplasia 8 9 . The incidence has also increased in the population over the past few decades 10 11 . There is a well-described progression within BE from non-dysplastic BE (NDBE), low-grade dysplasia (LGD), high-grade dysplasia (HGD), intramucosal carcinoma (IMC), to invasive EAC 12 13 . Recent data suggest that the increased incidence of EAC may have plateaued 1 . However, we questioned whether the prevalence of EAC is still increasing, especially at younger ages in lieu of recent trends showing an increase in the prevalence of colorectal cancer in younger patients. These findings resulted in a lowering of the colorectal cancer screening age cutoff to 45 years from 50 years 14 15 16 . Therefore, we aimed to assess the time trends in the prevalence and incidence of EAC and some of its risk factors in a large population of patients in Florida and to assess these trends based on age categories. We hypothesized that the prevalence of EAC and BE has increased over time at younger age groups.

Gastroesophageal reflux and Barrett’s esophagus: a pathway to esophageal adenocarcinoma

Molecular Evolution of Metaplasia to Adenocarcinoma in the Esophagus

The epidemic of esophageal adenocarcinoma

Barrett's Esophagus Risk Factors in Patients Without Gastroesophageal Reflux: A Large Population-Based Study

Esophageal Adenocarcinoma Arising from Barrett'S Epithelium in Taiwan

Recent insights into the biology of Barrett's esophagus

Molecular Mechanisms of Barrett’s Esophagus

Origins of Metaplasia in the Esophagus: Is This a GE Junction Stem Cell Disease?

Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma

Signaling Pathways in the Pathogenesis of Barrett's Esophagus and Esophageal Adenocarcinoma

The Role of Microbiota in the Pathogenesis of Esophageal Adenocarcinoma

Trends in prevalence of esophageal adenocarcinoma: Findings from a statewide database of over 6 million patients

[Barrett's Esophagus: Update on the Diagnosis and Treatment. Review]

Transcriptomic changes and gene fusions during the progression from Barrett's esophagus to esophageal adenocarcinoma

The role of bile acids in the neoplastic progression of Barrett's esophagus - a short representative overview

Visceral Obesity, Metabolic Syndrome, and Esophageal Adenocarcinoma

[Barrett's esophagus: Diagnosis, treatment and minimizing of risk]

Acid, bile, and CDX: the ABCs of making Barrett's metaplasia

Advance of Study on Bile Acids in Barrett's Carcinogenesis

Dietary Risk Reduction Factors for the Barrett's Esophagus-Esophageal Adenocarcinoma Continuum: A Review of the Recent Literature.

Data from Bile Acid Reflux Contributes to Development of Esophageal Adenocarcinoma Via Activation of Phosphatidylinositol-Specific Phospholipase Cγ2 and NADPH Oxidase NOX5-S